Latest News and Press Releases
Want to stay updated on the latest news?
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
New York, June 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Precast Concrete Industry" - https://www.reportlinker.com/p05799414/?utm_source=GNW -Online...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...
-
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "Global Password Policy Enforcement Software Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Deployment and Enterprise Size" report has...
-
New York, June 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Public Safety LTE Industry" - https://www.reportlinker.com/p05799459/?utm_source=GNW -Online...
-
VANCOUVER, British Columbia, June 27, 2022 (GLOBE NEWSWIRE) -- Bright Minds Biosciences (“Bright Minds,” “BMB” or the “Company”) (Nasdaq: DRUG) (CSE: DRUG), a biotechnology company focused on...
-
Dublin, June 27, 2022 (GLOBE NEWSWIRE) -- The "Global Battery Testing Equipment Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Product Type, Application, and End User and Others"...
-
New York, June 27, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Remote Monitoring and Control Industry" -...
-
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): ALK initiates a Phase I clinical trial of its novel investigational sublingual allergy immunotherapy (SLIT) tablet for the treatment of peanut allergy. The...